|4Feb 2, 4:24 PM ET

DesRoches Reginald 4

4 · TEXAS INSTRUMENTS INC · Filed Feb 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Texas Instruments (TXN) Director Reginald DesRoches Receives Award

What Happened Reginald DesRoches, a director of Texas Instruments (TXN), received director compensation awards on January 29, 2026. The Form 4 shows an acquisition (code A) of 525 shares at $0.00 and a derivative acquisition of 1,860 shares (restricted stock units) at $0.00 — a total of 2,385 shares granted as awards (no cash paid at grant).

Key Details

  • Transaction date: January 29, 2026; Form 4 filed February 2, 2026 (timely within SEC filing window).
  • Grants: 525 shares @ $0.00 (direct) and 1,860 derivative shares @ $0.00 (RSUs) — total 2,385 shares.
  • Reported value at grant: $0 (awards granted, not purchased).
  • Footnotes:
    • F1: Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan.
    • F2: “The stock option becomes exercisable in four equal installments beginning on January 29, 2027.” (as stated in filing)
  • Shares owned after the transaction: not specified in the provided summary of the filing.
  • Exhibit: Exhibit 24 (Power of Attorney) referenced.

Context This was a compensation award (grant), not an open-market purchase or sale. Director grants like RSUs are common routine compensation and do not by themselves indicate a buy/sell signal — they typically vest or become exercisable over time per the plan/footnote schedules. The filing appears timely (filed within the SEC’s two-business-day requirement).

Insider Transaction Report

Form 4
Period: 2026-01-29
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-29+5252,308 total
  • Award

    NQ Stock Option (Right to Buy)

    [F2]
    2026-01-29+1,8601,860 total
    Exercise: $218.97Exp: 2036-01-29Common Stock (1,860 underlying)
Footnotes (2)
  • [F1]Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan.
  • [F2]The stock option becomes exercisable in four equal installments beginning on January 29, 2027.
Signature
/s/ Shannon Thompson, Attorney in Fact|2026-02-02

Documents

2 files